Attached files

file filename
8-K - FORM 8-K - Vitamin Shoppe, Inc.d8k.htm
EX-2.1 - AGREEMENT AND PLAN OF MERGER - Vitamin Shoppe, Inc.dex21.htm
EX-99.2 - PRESS RELEASE, DATED OCTOBER 29 - Vitamin Shoppe, Inc.dex992.htm
EX-10.1 - SECURITYHOLDERS AGREEMENT - Vitamin Shoppe, Inc.dex101.htm
EX-99.3 - PRESS RELEASE, DATED NOVEMBER 2, 2009 - Vitamin Shoppe, Inc.dex993.htm

Exhibit 99.1

Vitamin Shoppe, Inc. Prices Initial Public Offering

North Bergen, NJ (October 28, 2009) — Vitamin Shoppe, Inc. (NYSE: VSI) today announced that the public offering of 9,096,077 shares of its common stock has priced at $17.00 per share. The shares will begin trading on the New York Stock Exchange on October 28, 2009 under the ticker symbol “VSI.” Vitamin Shoppe is offering 7,666,667 shares of common stock and selling stockholders are offering the remaining 1,429,410 shares in the offering. The underwriters have a 30-day option to purchase up to an additional 1,364,411 shares from the selling stockholders.

Vitamin Shoppe intends to use the net proceeds of approximately $121.2 million from the offering for the pro rata redemption of approximately $72.5 million of its outstanding preferred stock, the repurchase of approximately $45.2 million in aggregate principal amount of its outstanding senior secured notes, and the payment of offering-related expenses.

J.P.Morgan, BofA Merrill Lynch and Barclays Capital are acting as joint book-running managers for the offering. Piper Jaffray, Robert W. Baird & Co. and Stifel Nicolaus are the co-managers of the offering.

The public offering is being made only by means of a prospectus, copies of which may be obtained from either:

J.P.Morgan

c/o Broadridge Financial Solutions

1155 Long Island Ave

Edgewood, NY 11717

BofA Merrill Lynch

4 World Financial Center

New York, NY 10080

Attention: Preliminary Prospectus Department

Email: Prospectus.Requests@ml.com

Barclays Capital

c/o Broadridge Integrated Distribution Services

1155 Long Island Avenue

Edgewood, NY 11717

A registration statement relating to shares of the common stock of Vitamin Shoppe has been declared effective by the Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful.

About Vitamin Shoppe, Inc.

Vitamin Shoppe is a specialty retailer and direct marketer of nutritional products based in North Bergen, New Jersey. The company sells vitamins, minerals, nutritional supplements, herbs, sports nutrition formulas, homeopathic remedies, green living products and health and beauty aids to customers located primarily in the United States.


Investor Contact:

Michael Archbold

Chief Financial Officer

201-624–3611

ir@vitaminshoppe.com

Media Contact:

Susan McLaughlin

Director Corporate Communications

201-624-3134

smclaughlin@vitaminshoppe.com

Or:

Allison & Partners

Jill Yaffe

646-428-0602

vitaminshoppe@allisonpr.com